Personalized cancer screening platform that provides infrastructure to reduce late-stage cancer through deep risk stratification, screening completion support, and vendor-agnostic routing to appropriate screening modalities.
500
Users
$450K
Previous Round
Comprehensive cancer screening infrastructure covering five cancer types (breast, ovarian, prostate, colorectal, lung). Platform personalizes 5 and 10-year cancer risk using validated models, provides vendor-agnostic routing to appropriate screening modalities, manages complete workflow from scheduling to results, and continuously recalibrates risk models with real outcomes. Targets self-insured employers with 154M covered lives, addressing the $222B U.S. cancer care cost.
Click to read more